The effects of salm-calcitonin on breast cancer osteolytic skeletal metastases have been studied on conventional radiographs. Radiographic criteria for positive response have been defined. It is concluded that radiographs are inadequate for assessing the effects of salm-calcitonin.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/0720-048x(91)90111-8 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[Guidelines for drug therapy of postmenopausal osteoporosis].
Wien Med Wochenschr
April 2003
Klinischen Abteilung für Endokrinologie und Nuklearmedizin der Medizinischen Universitätsklinik, Auenbruggerplatz 15, A-8036 Graz.
Osteoporosis is known as a condition characterized by low bone mass and microarchitectural deterioration of bone tissue leading to bone fragility and a consequent susceptibility to fracture. Osteoporosis has its highest rate of occurrence in postmenopausal women, and in Western countries it has been estimated that for white women aged fifty, the life-time risk of developing an osteoporotic fracture is nearly 40%. Given the consequences of osteoporosis, the most important goal of therapy is to prevent fractures.
View Article and Find Full Text PDFConventional radiograms for assessment of salm-calcitonin therapy for bone metastases from breast carcinoma.
Eur J Radiol
July 1991
Central Institute for Cancer Research, Academy of Sciences, Berlin-Buch, F.R.G.
The effects of salm-calcitonin on breast cancer osteolytic skeletal metastases have been studied on conventional radiographs. Radiographic criteria for positive response have been defined. It is concluded that radiographs are inadequate for assessing the effects of salm-calcitonin.
View Article and Find Full Text PDF[Salmon calcitonin in metastatic bone pain. Demonstration of acute analgesia in tumor patients].
Dtsch Med Wochenschr
June 1984
Infusion of 200 IU Calcitonin-Sandoz in 20 of 44 hospitalized patients with malignant tumor suffering from chronic severe pain due to bone metastases, reduced the intensity of pain and with it the need for analgesics for an average of 10 hours. The result points to an analgesic potential of salmon-calcitonin.
View Article and Find Full Text PDF48 patients with metastatic breast cancer and extensive bone involvement were treated with salm-calcitonin and polychemo-therapy or hormonal treatment. They were compared with a control group of 73 patients without calcitonin therapy. One third of the patients from the calcitonin group referred pain relief which was obviously independent from the therapy effects of the polychemo or hormonal treatment.
View Article and Find Full Text PDF[Inhibition of gastroenteral absorption of 45Ca by synthetic salmon calcitonin (author's transl)].
Arzneimittelforschung
April 1982
In normocalcemic fasted rats the effect of synthetic salmon calcitonin (Calcitonin-Sandoz) at a dose of 0.1 ml/kg b.w.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!